Director – Global Medical Affairs - Omnichannel Transformation & Customer Experience
$192.1k - $252.1k/yr+ Annual bonus plan + Discretionary equity awards + Employee Stock Purchase Plan
Expert
Master's, PharmD, PhD, MD
Remote in USA
RemoteRemote in the US; travel up to 20%.
Biology & Biotech
About the job
Requirements
- An advanced degree (MS, PhD, PharmD, or MD) is required.
- At least 10 years of experience in the pharmaceutical, biotech, or life sciences industry, including at least 6 years in Medical Affairs, digital strategy, omnichannel engagement, customer experience, or related capability-building roles.
- Strong understanding of Medical Affairs, scientific communications, non-promotional engagement, and compliant content development.
- Demonstrated experience supporting Medical Affairs engagement across solid tumor and hematologic oncology therapeutic areas.
- Demonstrated experience translating strategy and customer insights into engagement plans, journeys, playbooks, or scalable operating models.
- Ability to simplify complexity and create clear frameworks that teams can understand, adopt, and scale.
- Strong customer experience mindset and ability to connect content, channels, data, field interactions, timing, and measurement into coordinated plans.
- Experience working across global, regional, and local stakeholders in a matrixed environment.
- Working knowledge of modular content, content operations, digital engagement, analytics, and customer data concepts.
- Ability to test new approaches while maintaining focus on quality, feasibility, compliance, and measurable value.
- Ability to influence without authority and bring clarity to ambiguous problems.
- High ownership, initiative, adaptability, and comfort building new capabilities in a fast-moving environment.
- Strong proficiency in Microsoft 365 and omnichannel engagement platforms, CRM, next-best-action (NBA) systems, analytics dashboards, content management systems (CMS), digital asset management (DAM) systems, Medical/Legal/Regulatory review platforms, healthcare professional (HCP) insights platforms, Veeva/Vault Medical, third-party media platforms, generative AI, and AI-enabled engagement and content capabilities.
- Ability to learn new platforms quickly.
- Ability to travel up to 20%.
Responsibilities
- Advance customer experience planning by defining how Medical Affairs engagement can be designed around customer needs, moments that matter, scientific priorities, and measurable outcomes.
- Partner with global and regional Medical Affairs teams to translate strategy, customer insights, and key scientific messages into practical engagement plans across relevant channels and touchpoints.
- Design holistic customer journeys that connect digital, field-enabled, congress, third-party, web, email, social, and other engagement channels to create coordinated, relevant scientific engagement.
- Apply segmentation, behavioral insights, customer preferences, and performance data to improve relevance, sequencing, personalization, and coordination of scientific engagement.
- Partner with Scientific Communications, Publications, Medical Information, Field Medical, and content partners to ensure scientific content supports the customer journey, key messages, channel needs, and engagement objectives.
- Advance scalable content approaches that improve reuse, modularity, discoverability, fit-for-channel adaptation, and speed while preserving scientific rigor and non-promotional standards.
- Define content requirements for omnichannel engagement plans, including content needs, channel fit, adaptation requirements, measurement approach, and opportunities to maximize reuse and impact.
- Collaborate with internal and external partners to streamline content activation, Medical/Legal/Regulatory review considerations, and channel readiness, and explore opportunities to scale content and improve efficiency using AI.
- Identify, pilot, and scale capabilities that improve customer experience, engagement effectiveness, and operational efficiency, including AI-supported workflows, analytics, personalization, content discoverability, and emerging engagement models.
- Define success measures and closed-loop learning approaches that connect customer insights, engagement data, content performance, field feedback, and business priorities to optimization decisions.
- Translate data and learnings into clear recommendations that improve customer journeys, engagement planning, capability roadmaps, and resource prioritization.
- Advance innovation with a practical focus on operational excellence, compliance, governance, and the evolving needs of global and local Medical Affairs teams.
- Build scalable frameworks, playbooks, templates, and standards that help Medical Affairs teams plan and orchestrate customer-centered engagement consistently across franchises and markets.
- Codify emerging best practices from the Omnichannel Center of Excellence into practical guidance that teams can adopt, adapt, and scale locally.
- Lead education, workshops, and change-management efforts that build omnichannel acumen and strengthen proactive customer experience planning across Medical Affairs teams.
- Establish clear ways of working, governance expectations, and partnership models that enable efficient planning while maintaining compliance, quality, and scientific integrity.
- Lead through influence, mentor peers and partners, and serve as a functional leader for omnichannel customer experience planning and capability-building.
About the company
BeOne Medicines develops and commercializes cancer therapies for patients worldwide, focusing on hematologic cancers and solid tumors. Its products, including Brukinsa, are sold globally and supported by licensing partnerships, with internal R&D and clinical development driving a broad late-stage pipeline. BeOne differentiates itself by leveraging a large-scale clinical trial network and cost-efficient global drug development to achieve high margins while pursuing large-market indications. The company aims to expand into immunology and solid tumors while maintaining strong investment in R&D to make high-impact, accessible oncology treatments available in more than 45 countries.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Dongcheng District, China
Founded
2010
Get referred to BeOne
See people who can refer or advise you
Simplify's Take
What believers are saying
- August 25, 2026 FDA approval expanded TEVIMBRA in first-line HER2-positive gastroesophageal cancer.
- August 31, 2026 Phase 3 survival data strengthened ZIIHERA-containing regimens.
- Q2 2026 revenue hit $1.7 billion; management raised 2026 guidance to $6.8 billion.
What critics are saying
- BeOne accepted developed-market pricing parity and Medicaid rebates on future U.S. approvals.
- Zydus' BRUKINSA ANDA lawsuit targets patents; a 2034 composition patent remains the fortress.
- AbbVie's trade-secrets case over BGB-16673 still threatens the BTK-degrader franchise.
What makes BeOne unique
- BeOne built 35-plus assets and 93 trials across 1,100 U.S. sites by September 2026.
- BRUKINSA dominates revenue, with 2026 global sales above $1.2 billion quarterly.
- Hopewell, New Jersey gives BeOne U.S. manufacturing, R&D, and packaging capacity.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- 401(k) Retirement Plan
- Wellness Program
- Paid Vacation